According to Odaily Planet Daily, MAIA Biotechnology, listed on the NYSE American subsidiary of the New York Stock Exchange, has officially launched its crypto treasury strategy. Its board of directors has approved investing 90% of the company's liquid assets in leading cryptocurrencies, initially in BTC, ETH, and USDC. The company will also reportedly establish a Digital Asset Advisory Committee to support related purchases. (Globenewswire)